Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PROVECTUS BIOPHARMACEUTICALS, INC. | PRESIDENT, Director | Series D-1 Convertible Preferred Stock | 1.34M | Sep 30, 2024 | Direct | ||
PROVECTUS BIOPHARMACEUTICALS, INC. | PRESIDENT, Director | Series D Convertible Preferred Stock | 0 | Jun 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Sep 30, 2024 | 1 | $0 | 4 | Sep 30, 2024 | PRESIDENT, Director |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Jun 25, 2024 | 2 | $0 | 4 | Jul 23, 2024 | PRESIDENT, Director |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Sep 16, 2022 | 1 | $3.27M | 4 | Sep 20, 2022 | Director |